EW - Edwards Lifesciences Corporation
| Previous Close | 149.88 |
| Open | 148.57 |
| Bid | 149.33 x 900 |
| Ask | 149.43 x 800 |
| Day's Range | 147.63 - 152.85 |
| 52 Week Range | 107.49 - 175.00 |
| Volume | 1,093,363 |
| Avg. Volume | 1,696,955 |
| Market Cap | 31.28B |
| Beta (3Y Monthly) | 0.84 |
| PE Ratio (TTM) | 45.03 |
| EPS (TTM) | 3.32 |
| Earnings Date | Jan 30, 2019 - Feb 4, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 161.58 |
- Zacks•7 hours ago
Edwards Lifesciences' CE Mark for SAPIEN 3 Boosts THVT Arm
Latest CE Mark receipt is expected to fortify Edwards Lifesciences' (EW) position in Europe.
- PR Newswire•4 days ago
Edwards' SAPIEN 3 Ultra Transcatheter Heart Valve Receives CE Mark
IRVINE, Calif., Nov. 16, 2018 /PRNewswire/ -- Edwards Lifesciences Corporation (EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it has received CE Mark for the SAPIEN 3 Ultra system for transcatheter aortic valve replacement in severe, symptomatic aortic stenosis patients. "The SAPIEN 3 Ultra system incorporates enhancements to the valve, as well as a new delivery system, which are designed to further build on the exceptional outcomes of the SAPIEN 3 valve, which has shown extremely low rates of mortality and disabling stroke," said Larry L. Wood, Edwards' corporate vice president, transcatheter heart valves.
- Simply Wall St.•8 days ago
Edwards Lifesciences Corporation (NYSE:EW): Financial Strength Analysis
Investors looking for stocks with high market liquidity and little debt on the balance sheet should consider Edwards Lifesciences Corporation (NYSE:EW). With a market valuation of US$32.0b, EW is a Read More...
Markit•10 days agoSee what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Zacks•15 days ago
Edwards Lifesciences (EW) Stock Sinks As Market Gains: What You Should Know
Edwards Lifesciences (EW) closed the most recent trading day at $149.75, moving -1.99% from the previous trading session.
Markit•18 days agoSee what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- GlobeNewswire•21 days ago
Report: Developing Opportunities within Merit Medical, Edwards Lifesciences, Norfolk Southern, Chipotle Mexican Grill, SLM, and Dril-Quip — Future Expectations, Projections Moving into 2018
NEW YORK, Oct. 30, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Markit•24 days agoSee what the IHS Markit Score report has to say about Edwards Lifesciences Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Zacks•25 days ago
The Zacks Analyst Blog Highlights: Boeing, Texas Instruments, General Dynamics, American International, TD Ameritrade and Edwards Lifesciences
The Zacks Analyst Blog Highlights: Boeing, Texas Instruments, General Dynamics, American International, TD Ameritrade and Edwards Lifesciences
- Investor's Business Daily•27 days ago
This IBD 50 Stock Jumped As Earnings, Organic Growth Topped Views
Boston Scientific stock jumped Wednesday on better-than-expected adjusted earnings and organic sales growth though, numerically, total revenue lagged.
- Thomson Reuters StreetEvents•26 days ago
Edited Transcript of EW earnings conference call or presentation 23-Oct-18 9:00pm GMT
Q3 2018 Edwards Lifesciences Corp Earnings Call
- Associated Press•27 days ago
Boeing rises while UPS and iRobot drop
Stocks that moved substantially or traded heavily Wednesday: Boeing Co., up $4.60 to $354.65 The company raised its annual forecasts after a strong quarter and said airlines ordered planes at a faster ...
- Investor's Business Daily•28 days ago
Edwards Topples After German Court Sides With Boston In Heart-Valve Case
Edwards Lifesciences toppled Tuesday after a German court sided with Boston Scientific in a patent case involving its nonsurgical heart-valve replacement.
- Investor's Business Daily•28 days ago
This Highly Rated Medtech Stock Just Reported A Mixed Third Quarter
Edwards Lifesciences reported a mixed third-quarter late Tuesday — prodding Edwards stock to initially dip before flattening.
- Reuters•27 days ago
Surgical product sales drive Boston Scientific's profit beat
Medical device company Boston Scientific Corp posted a slightly better-than-expected quarterly profit on Wednesday, helped by higher sales in its MedSurg business, which makes surgical products for various ...
- Zacks•27 days ago
Edwards Lifesciences (EW) Earnings Beat, Revenues Miss in Q3
Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q3.
- The Wall Street Journal•27 days ago
[$$] Stocks to Watch: Boeing, AT&T, UPS, Capital One, and More
Here are some of the companies with shares expected to trade actively in Wednesday’s session. Stock movements noted by ticker reflect movements during regular trading hours; premarket trading is specified separately.
- ACCESSWIRE•27 days ago
Today's Research Reports on Trending Tickers: Edwards Lifesciences and Acadia Healthcare Company
Edwards Lifesciences' stock moved 0.68% lower Tuesday, to close the day at $148.30. The stock recorded a trading volume of 2,943,065 shares, which was above its three months average volume of 1,573,616 shares. In the last year, Edwards Lifesciences' shares have traded in a range of 100.20 - 175.00.
Motley Fool•28 days agoEdwards Lifesciences Corp (EW) Q3 2018 Earnings Conference Call Transcript
EW earnings call for the period ending September 30, 2018.
- Investing.com•28 days ago
Edwards Lifesciences Earnings beat, Revenue misses In Q3
Investing.com - Edwards Lifesciences (NYSE:EW) reported third quarter earnings that beat analyst's expectations on Tuesday and revenue that fell short of forecasts.
- Associated Press•28 days ago
Edwards Lifesciences: 3Q Earnings Snapshot
On a per-share basis, the Irvine, California-based company said it had profit of $1.06. Earnings, adjusted for one-time gains and costs, were $1.07 per share. The results exceeded Wall Street expectations. ...
- PR Newswire•28 days ago
Edwards Lifesciences Reports Third Quarter Results
IRVINE, Calif. , Oct. 23, 2018 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today ...
- Investor's Business Daily•28 days ago
Dow Falls 400 Points As Market Correction Deepens; Centene Falters
The Dow Jones industrial average fell over 400 points on weak earnings results from Caterpillar and 3M. Top growth stock Centene faltered.
- Simply Wall St.•28 days ago
With A -8.3% Earnings Drop, Did Edwards Lifesciences Corporation (NYSE:EW) Really Underperform?
Examining Edwards Lifesciences Corporation’s (NYSE:EW) past track record of performance is a useful exercise for investors. It allows us to reflect on whether the company has met or exceed expectations, Read More...
- Yahoo Finance Contributors•16 days ago
5 Trade Ideas for Monday: Commerce Bancshares, Edwards Lifesciences, Five Below, Illumina & United Continental
